Revvity jumps after lifting 2025 adjusted profit outlook

Revvity

13/01/2026 14:59

** Medical equipment maker Revvity's RVTY.N shares surge 8.6% to $112.85, touching a over 9-month high

** Co
said late on Monday
 its 2025 adjusted profit per share will exceed its prior forecast of $4.90 to $5.00

** RVTY expects Q4 revenue of around $772 million, above analysts' estimates of $760.3 million

** Co sees 2025 revenue growing at 4% to $2.86 billion, above estimates of $2.84 billion

** "We are curious if life sciences came in a tad better, given peer Danaher DHR.N noted slightly better pharma sentiment," Evercore ISI says

** "Given the improved Q4 exit rate, we wonder if RVTY points to high end of prior issued 2-3% outlook for FY26," brokerage adds

** As of last close, stock has fell 15.3% in past 12 months

 (Reporting by Siddhi Mahatole)

 ((siddhi.mahatole@thomsonreuters.com))